跳至主要内容
临床试验/NCT05008068
NCT05008068已完成1 期

Effect of Local Application of Platelet-rich Fibrin Scaffold Loaded With Simvastatin on Peri-implant Bone Changes

British University In Egypt1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2019年8月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
8
试验地点
1
主要终点
The measurement of bone thickness

研究概览

简要总结

ACKGROUND: Simvastatin (SIM), a pharmacological drug used for hypercholesterolemia, has been found to have pleotropic effects on bones. Simvastatin together with the appropriate carrier may decrease bone loss around implants.

PURPOSE: To compare the long term effects of autologous PRF alone, and PRF loaded with SIM on peri-implant bone changes and implant stability in patients undergoing implant rehabilitation.

MATERIALS AND METHODS: A randomized controlled split-mouth studyincluding 8 males between the ages of 45-60 years. Each patient received two implants, one on each side of the arch. One side was treated with PRF alone and the other side with PRF +Simvastatin, at the time of Osteotomy. A cone-beam CT was used to evaluate bone changes around the insertion of implant sites atthree, six, and twelve months postoperatively. The secondary outcome included measuring implant stability using Ostell device at baseline and 3 months post insertion. To compare groups at different time periods, data was examined using a two-way (ANOVA) analysis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Participant)

入排标准

年龄范围
45 Years 至 60 Years(Adult)
接受健康志愿者

入选标准

  • patients with a partially edentulous mandible indicated for rehabilitation with implant prostheses,
  • any extractions, or surgeries performed at least six months earlier.

排除标准

  • patients with systemic diseases affecting bone quality or resorption
  • temporomandibular joint dysfunction,
  • severe attrition or parafunctional habits,
  • patients undergoing radiotherapy or chemotherapy,
  • heavy smokers,
  • vulnerable groups such as psychologically unstable patients

研究组 & 干预措施

PRF alone

Experimental

干预措施: Simvastatin (Drug)

PRF in addition to Simvastatin

Active Comparator

干预措施: Simvastatin (Drug)

结局指标

主要结局

The measurement of bone thickness

时间窗: After 12 months of the osteotomy and application of Simvastatin

Measuring unit in millimeters , measuring device is CBCT software

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Fikry El Shafei

Principal investigator

British University In Egypt

研究点 (1)

Loading locations...

相似试验